(19)
(11) EP 4 558 821 A1

(12)

(43) Date of publication:
28.05.2025 Bulletin 2025/22

(21) Application number: 23745124.0

(22) Date of filing: 20.07.2023
(51) International Patent Classification (IPC): 
G01N 33/563(2006.01)
G01N 33/68(2006.01)
(52) Cooperative Patent Classification (CPC):
G01N 33/689; G01N 2333/50; G01N 2333/52; G01N 2800/52
(86) International application number:
PCT/EP2023/070111
(87) International publication number:
WO 2024/017988 (25.01.2024 Gazette 2024/04)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 22.07.2022 EP 22186507

(71) Applicants:
  • F. Hoffmann-La Roche AG
    4070 Basel (CH)

    AL AT BE BG CH CY CZ DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR 
  • Roche Diagnostics GmbH
    68305 Mannheim (DE)

    DE 

(72) Inventors:
  • MARTIN, Klammer
    82377 Penzberg (DE)
  • MANG, Anika
    82377 Penzberg (DE)
  • ALLEGRANZA, Deirdre
    6343 Rotkreuz (CH)
  • DI DOMENICO, Annunziata
    6343 Rotkreuz (CH)
  • HUND, Martin
    6343 Rotkreuz (CH)
  • SILLMAN, Johanna
    6343 Rotkreuz (CH)

(74) Representative: Flosdorff, Sandra Lisa 
Roche Diagnostics GmbH Patentabteilung Nonnenwald 2
82377 Penzberg
82377 Penzberg (DE)

   


(54) RATIO BETWEEN FGFBP1 AND METRNL IN THE ASSESSMENT OF POLYCYSTIC OVARIAN SYNDROME